Meet our team
Meet the team behind TRPL, a group of experienced and highly trained professionals dedicated to providing integrated solutions for our clients. With years of industry experience and a passion for excellence our team is committed to delivering exceptional results and exceeding expectations. Get to know us and discover how we can help achieve your goals.
Fotios Plakogiannis, Ph.D
Managing Partner
Dr. Plakogiannis served as a professor in the Arnold & Marie Schwartz College of Pharmacy at Long Island University for over 45 years and for over 25 years was the Director of the Division of Pharmaceutical Sciences of the College. He was instrumental in establishing the Scientific Graduate Division (MS and Ph.D. program) and was the recipient of the TASA Award for Lifetime Achievement Award, Founder Award, among numerous other prestigious awards. Dr. Plakogiannis has authored three books and more than 100 research papers with the majority in the area of Transdermal Delivery. He has mentored more than 200 MS and Ph.D. degrees, served as Chair of the Academy of Pharmaceutical Sciences Basic Pharmaceutical Section, and has presented his work in the USA and Europe. Dr. Plakogiannis has been a visiting professor at a number of universities, including but not limited to Kentucky University and the University of Arizona. In addition, he has served as a consultant for the pharmaceutical industry and has served as an expert witness in several cases. Dr. Plakogiannis holds a diploma from the University of Athens (Greece), a Masters degree from Ohio State University, and a Doctor of Philosophy from the University of Southern California.
Tamanna Lather, M.S.
Director of Research and Development
Roda Plakogiannis, Pharm. D
Associate Managing Partner
Dr. Plakogiannis served as a professor of Pharmacy practice at the Arnold & Marie Schwartz College of Pharmacy at Long Island University for 20 years. For five years, she established and served as residency director of the PGY-2 ambulatory care program, LIU-Pharmacy @NYU Langone Health. Dr. Plakogiannis is a Board-Certified Pharmacotherapy Specialist, Board Certified Ambulatory Care Pharmacist, Diplomate and Fellow of the Accreditation Council for Clinical Lipidology, and a Board-Certified Clinical Lipid Specialist. Her work has been presented nationwide, and she has been an invited speaker to numerous speaking engagements and served on the Advisory Board of multiple pharmaceutical companies. She is nationally recognized in lipidology and has published over 40 papers and authored textbook chapters. She received her Bachelor of Science in Pharmacy and Doctor of Pharmacy degree at the Arnold & Marie Schwartz College of Pharmacy. Subsequently, she completed an ASHP-accredited specialized pharmacy residency in primary care at the Bay Pines VA in Tampa, Florida.
Yuliya Levintova, Ph.D
Manager, Long Island City Laboratory
Senior Scientist
Nisarg Modi, Ph.D
Scientist, Consultant
Marina Borovinskay, Ph. D.
Scientific Consultant
Dr. Marina Borovinskaya is a scientist with over 10 years of laboratory and research experience in the pharmaceutical science field. She graduated from Long Island University with a Ph.D. in Pharmaceutical Science in Transdermal Drug Delivery. Before joining TRPL Dr. Borovinskaya was a part of the formulation team in the R&D department in Sigmapharm Laboratories which was engaged in the development, manufacturing, and marketing of unique generic and brand products. Dr. Borovinskaya has extensive experience in the formulation design and development of unique drugs via transdermal patches.
Socrates Georgiou
Consultant, Lab Co-ordinator,
IT Specialist
Socrates Georgiou attended Derry College majoring in Information Technology, Network Management and is A+ certified by CompTia. Prior to. moving to New York, he lived in Cyprus and London working in various industries including the military, police, hospitality and real estate. Mr. Georgiou's extensive skill set has been a great asset to TRPL since joining our team in 2020. Mr. Georgiou manages all IT infrastructure and is our Lab co-ordinator.
Tamanna Lather is working as The Director of Research and Development at TRPL. She received her B.S. Pharmacy and Post Graduate Diploma in Pharmaceutical Regulatory Affairs from India, and her M.S. Pharmaceutics with specialization in transdermal drug delivery from Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University. During her Masters, she was selected as a scholar in the Rho Chi Society. She has 10 years of research and development experience in Transdermal Drug Delivery. Her expertise is in developing transdermal gel and matrix patch with multiple day drug delivery. She is co-author of several patents and patent applications. Her work in transdermal drug delivery development has successfully reached animal studies and clinical trials. She has strong analytical and quantitative skills, her inquisitiveness and determination, drive her to contribute to Transdermal Drug Delivery Development.
Yuliya Levintova is the manager of the TRPL Long Island City Lab and a Senior Scientist at Transdermal Research Laboratories, LLC. Dr. Levintova completed her Ph.D. in Pharmaceutical Science from the Division of Pharmaceutical Science at Long Island University in the area of Transdermal Drug Delivery. Prior to joining TRPL, Dr. Levintova had about 10 years of experience in the generic pharmaceutical industry. She was a part of the formulation team at Hi-Tech Pharmacal and Manager of Product Development at Saptalis Pharmaceuticals, LLC. She accomplished hands-on R&D experience with broad development and innovation in prescription products. She has pharmaceutical expertise in product and process development including formulation of semisolid dosage forms (gels, creams, ointments, and pastes), oral liquid formulations (suspensions, solutions) as well as nasal and ophthalmic dosage forms (solutions, gel-forming solutions, and suspensions). Dr. Levintova has strong skills in team leadership, effective communication, product lifecycle management, and cross-functional collaboration.
Dr. Modi is a Director of R&D at TRPL, LLC. Dr. Modi completed his Bachelor of Pharmacy from Sardar Patel University, India, and received his M.S. and Ph.D. from the Division of Pharmaceutical Science at Long Island University, Brooklyn. Dr. Modi has expertise in developing transdermal drug delivery systems for new chemical entities (NCE) and approved drug products through the 505 (b)2 pathway with successful clinical trials. He has more than 10 years of experience in controlled release product development with a strong emphasis on multiple-day transdermal drug delivery systems. His work in transdermal drug delivery has resulted in a number of patents. Prior to joining TRPL, he volunteered at the High Throughput Screening (HTS) core-facility of Memorial Sloan Kettering cancer center to determine the solubility of HTS library compounds using novel Nephelometry technique. He acquired solid dosage formulation development and manufacturing experience by working at Apex Pharmaceuticals Inc., Torrent Pharmaceutical Ltd., and Lincoln Pharmaceutical Ltd. Dr. Modi is a Director of R&D at TRPL, LLC. Dr. Modi completed his Bachelor of Pharmacy from Sardar Patel University, India, and received his M.S. and Ph.D. from the Division of Pharmaceutical Science at Long Island University, Brooklyn. Dr. Modi has expertise in developing transdermal drug delivery systems for new chemical entities (NCE) and approved drug products through the 505 (b)2 pathway with successful clinical trials. He has more than 10 years of experience in controlled release product development with a strong emphasis on multiple-day transdermal drug delivery systems. His work in transdermal drug delivery has resulted in a number of patents. Prior to joining TRPL, he volunteered at the High Throughput Screening (HTS) core-facility of Memorial Sloan Kettering cancer center to determine the solubility of HTS library compounds using novel Nephelometry technique. He acquired solid dosage formulation development and manufacturing experience by working at Apex Pharmaceuticals Inc., Torrent Pharmaceutical Ltd., and Lincoln Pharmaceutical Ltd.
Don McAfee, Ph. D.
Scientific Consultant
Dr. Donald McAfee has been a scientist and manager in academia and industry for more than 40 years. His undergraduate studies were at the University of Chicago and Portland State University, and he earned his Ph.D. at the University of Oregon School of Medicine (OHSU) in Physiology. He did his postdoctoral studies at Yale University under Dr. Paul Greengard, Nobel Laureate. During a long academic career researching ion channel pharmacology and biophysics in excitable tissues at Yale University, University of Miami, Beckman Research Institute, and the University of British Columbia, he published more than 100 scientific papers. Dr. McAfee has served as a VP and chief scientific officer at Nelson Research, Whitby Pharmaceuticals, Cardiome Pharma, and Aequus Pharma. He founded Discovery Therapeutics and led the initial development of Neupro™, a transdermal patch for the treatment of Parkinson's Disease and Restless Leg Syndrome now marketed worldwide.